News & Updates

IBP-9414 improves GI outcomes, cuts death rates in VLBW infants

29 May 2025 by

IBP-9414, a live biotherapeutic product (LBP), delivers gastrointestinal (GI) and mortality benefits in very low birth weight (VLBW) infants (BW 500–1,500g) born between 23 and 32 weeks gestational age in the phase III Connection study presented at PAS 2025.

IBP-9414 improves GI outcomes, cuts death rates in VLBW infants

29 May 2025

Dietary polyunsaturated fatty acid protective against rheumatoid arthritis

29 May 2025

Dietary intake of polyunsaturated fatty acids (PUFAs) helps reduce the risk of rheumatoid arthritis (RA), as reported in a study.

Dietary polyunsaturated fatty acid protective against rheumatoid arthritis

29 May 2025

Original New Drug Application Approvals by US FDA (16-30 April 2025)

29 May 2025

New drug applications approved by US FDA as of 16-30 April 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-30 April 2025)

29 May 2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-May-2025

29 May 2025

New drug applications approved by US FDA as of 1-15 May 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-May-2025

29 May 2025

Ultraprocessed foods linked to arthritis

28 May 2025

Consuming ultraprocessed foods at high amounts contributes to increased risk of overall arthritis and rheumatoid arthritis, according to a study.

Ultraprocessed foods linked to arthritis

28 May 2025

Androgenetic alopecia may develop in prepubertal patients

28 May 2025

Prepubertal children can develop androgenetic alopecia (AGA), suggests a study. Obesity and family history are associated with an increased risk for paediatric AGA.

Androgenetic alopecia may develop in prepubertal patients

28 May 2025

Adolescent fitness lowers cancer risk in adulthood

28 May 2025 by

High cardiorespiratory fitness during adolescence appears to provide protection against cancer development and death in late adulthood, suggests a study. This finding is consistent in sibling comparisons.

Adolescent fitness lowers cancer risk in adulthood

28 May 2025

Multiple skin cancers can occur in treated patients, says study

28 May 2025

A recent study claims that almost half of the patients treated for skin cancer will again develop the disease within 2 years of the first incidence.

Multiple skin cancers can occur in treated patients, says study

28 May 2025

10-year data reflect teduglutide efficacy for SBS-IF

28 May 2025 by

An interim analysis of a real-world study reporting up to 10 years of follow-up data shows that teduglutide, a human glucagon-like peptide-2 analogue, can provide long-term reductions in parenteral nutrition and/or intravenous fluid (PN/IV) requirements and shorter time to achieve enteral autonomy in adults with short bowel syndrome-associated intestinal failure (SBS-IF).

10-year data reflect teduglutide efficacy for SBS-IF

28 May 2025

β-lactam/β-lactamase inhibitor combination noninferior to piperacillin/tazobactam for pneumonia

28 May 2025

In the treatment of adults with hospital-associated (HABP) or ventilator-associated bacterial pneumonia (VABP), the β-lactam/β-lactamase inhibitor combination imipenem/cilastatin/relebactam appears to be as good as piperacillin/tazobactam, with similar safety profiles, according to a phase III trial.

β-lactam/β-lactamase inhibitor combination noninferior to piperacillin/tazobactam for pneumonia

28 May 2025

News & Updates

Filter by Specialty:

Specialty:

IBP-9414 improves GI outcomes, cuts death rates in VLBW infants

IBP-9414 improves GI outcomes, cuts death rates in VLBW infants

Dietary polyunsaturated fatty acid protective against rheumatoid arthritis

Dietary polyunsaturated fatty acid protective against rheumatoid arthritis

Original New Drug Application Approvals by US FDA (16-30 April 2025)

Original New Drug Application Approvals by US FDA (16-30 April 2025)

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-May-2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-May-2025

Ultraprocessed foods linked to arthritis

Ultraprocessed foods linked to arthritis

Androgenetic alopecia may develop in prepubertal patients

Androgenetic alopecia may develop in prepubertal patients

Adolescent fitness lowers cancer risk in adulthood

Adolescent fitness lowers cancer risk in adulthood

Multiple skin cancers can occur in treated patients, says study

Multiple skin cancers can occur in treated patients, says study

10-year data reflect teduglutide efficacy for SBS-IF

10-year data reflect teduglutide efficacy for SBS-IF

β-lactam/β-lactamase inhibitor combination noninferior to piperacillin/tazobactam for pneumonia

β-lactam/β-lactamase inhibitor combination noninferior to piperacillin/tazobactam for pneumonia